Dear Allstat,
Senior / Principle Statistician - North of England
Call 0207 255 66 00 for a confidential discussion and full details of this
position.
Join a specialist pharmaceutical company with a strong preclinical and
clinical pipeline at a time of massive growth and opportunity.
This company is a world leader in scar prevention and reduction research,
developing pharmaceutical products to prevent and reduce scarring in the
skin, blood vessels, eyes, nerves, internal organs, tendons and ligaments.
Due to a strategic move to take the Biometrics functions in-house this
company is seeking top talent to be at the forefront of this new department
and drive the operational development of a range of investigational
products. In this role you will act as Project Statistician and will be
responsible for all statistical aspects of the design, planning and
development of assigned clinical studies. This is a challenging opportunity
offering a significant platform for career progression.
We are looking for experienced Biostatisticians with a minimum of 4 years
relevant experience. You will have Lead Statistician experience, ideally on
Phase II/III studies and strong SAS analysis skills (SAS/Base, SAS/Macro,
SAS/Graph, SAS/Stat).
Forward your CV with a short cover note detailing your salary expectations
and notice period or call 0207 255 66 00 to learn more.
Kind regards,
Alan
Alan Brophy
SEC Recruitment, London
Tel: 0207 255 66 00
Fax: 0207 255 66 01
<mailto:[log in to unmask]> [log in to unmask]
SEC are an ISO9001:2000 accredited specialist recruitment company working
within the Pharmaceutical, Biotech and CRO industries. If you are interested
to learn more about further appointments within Biostatistics or Statistical
Programming across the UK and Mainland Europe contact Alan on 020 7 255 6600
for a confidential discussion.
This email is confidential and intended solely for the use of the
individual to whom it is addressed. Any views or opinions presented are
solely those of the author and do not represent those of the company from
which the email was sent. If you are not the intended recipient, be advised
that you have received this e-mail in error and that any use, dissemination
forwarding, printing or copying of this e-mail is strictly prohibited.
While every effort has been made to scan this e-mail, we can not accept any
responsibility for loss of business or damage caused arising from this
e-mail.
|